Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Arcutis Biotherapeutics Inc (ARQT)

Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bull & Bear - Bull on Wall Street by Alexander Naumann via Pixabay
3 'Strong-Buy'-Rated Russell 2000 Stocks With 54% to 110% Upside Barchart - Fri Aug 9, 6:30AM CDT

Investing in these small caps could be rewarding in the long run.

VKTX : 70.47 (+3.39%)
ARQT : 10.15 (+0.10%)
LBPH : 33.89 (+1.47%)
$SPX : 5,702.55 (-0.19%)
Healthcare - stethoscope-with-injection-protective-mask-lying-over-medical-chart-SBI-300904603
5 Breakout Biotech Stocks Leading the Russell 2000 Higher Barchart - Thu May 23, 12:52PM CDT

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

JANX : 50.20 (+0.44%)
VKTX : 70.47 (+3.39%)
LBPH : 33.89 (+1.47%)
ARQT : 10.15 (+0.10%)
RNA : 44.48 (-2.56%)
Wall Street - shutterstock_2269106477
S&P Futures Higher After April CPI is Released Barchart - Wed May 15, 4:34AM CDT

June S&P 500 E-Mini futures (ESM24) are trending up +0.45% this morning after April's CPI report was released.

ESM24 : 5,471.89s (-0.09%)
SMCI : 457.27 (+4.59%)
ORCL : 168.00 (+0.24%)
SCHW : 65.39 (+0.97%)
PARA : 10.37 (-0.86%)
CSCO : 51.97 (+1.03%)
GRAB : 3.64 (-0.55%)
MNDY : 280.17 (+2.13%)
EXPN.LN : 3,812.000 (-1.70%)
MRK.D.DX : 157.400 (-5.52%)
NESTE.H.DX : 16.750 (unch)
ARQT : 10.15 (+0.10%)
Wall Street - shutterstock_93231562
S&P Futures Slip as Investors Cautiously Await U.S. Big Bank Earnings, U.S. Rates Stay in Focus Barchart - Fri Oct 13, 2023

December S&P 500 futures (ESZ23) are trending down -0.24% this morning after three major U.S. benchmark indices closed lower on Thursday as hotter-than-expected U.S. inflation data bolstered bets on Federal...

ESZ23 : 4,694.27s (-0.58%)
DAL : 46.94 (-0.40%)
F : 10.88 (-0.37%)
BYND : 6.36 (+0.47%)
FAST : 70.75 (-0.88%)
JPM : 211.09 (+0.29%)
WFC : 56.29 (+0.88%)
C : 62.14 (-1.40%)
BLK : 928.79 (-0.65%)
PNC : 186.36 (-0.45%)
UNH : 575.00 (-0.36%)
DIM.FP : 171.500 (-5.41%)
Why Shares of Arcutis Biotherapeutics Fell This Week Motley Fool - Thu Sep 7, 2023

The company released phase 3 trial results for an atopic dermatitis cream.

ARQT : 10.15 (+0.10%)
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (Nasdaq: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the...

AGLE : 12.01 (+8.79%)
ARQT : 10.15 (+0.10%)
Why Shares of Arcutis Biotherapeutics Jumped This Week Motley Fool - Fri Jun 9, 2023

The stock got a push when a British medical journal posted trials information on the company's lead product.

ARQT : 10.15 (+0.10%)
MyHealthTeam and Arcutis Biotherapeutics Launch New Social Network for People Living with Seborrheic Dermatitis PR Newswire - Thu Dec 1, 2022

/PRNewswire/ -- MyHealthTeam, creator of the largest and fastest-growing social networks for people living with chronic health conditions, today launched...

ARQT : 10.15 (+0.10%)
LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million PR Newswire - Thu Sep 8, 2022

/PRNewswire/ -- LifeArc today announced that its portfolio company DucentisBioTherapeutics, a preclinical-stage biotechnology company focused on developing...

ARQT : 10.15 (+0.10%)
NEW CAMPAIGN FROM ARCUTIS AIMS TO EXPOSE THE IMPACT OF PSORIASIS ON PHYSICAL, MENTAL, AND EMOTIONAL WELLBEING PR Newswire - Tue Aug 30, 2022

/PRNewswire/ -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) today announced the launch of an educational campaign designed to raise awareness about the...

ARQT : 10.15 (+0.10%)

Barchart Exclusives

4 Outstanding High-Yield Dividend Stocks to Pounce On Now Barchart - Fri Sep 20, 1:05PM CDT
These high-yield dividend payers could be a good choice for income-seeking investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot